Novel Cu(II) Schiff Base Complex Combination with Polymyxin B/Phenylalanine-Arginine β-Naphthylamide Against Various Bacterial Strains
Concerns on increasing trends of multidrug resistance (MDR) around the world have triggered the need to investigate and develop new therapeutic strategies and potent antibacterial drugs. Polymyxins, a class of polycationic antimicrobial peptides, have been regarded as the last-line therapy against G...
Gespeichert in:
Veröffentlicht in: | International journal of peptide research and therapeutics 2022-03, Vol.28 (2), Article 60 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 2 |
container_start_page | |
container_title | International journal of peptide research and therapeutics |
container_volume | 28 |
creator | Gan, Wei Khang Liew, Hui Shan Pua, Lesley Jia Wei Ng, Xiao Ying Fong, Kar Wai Cheong, Siew Lee Liew, Yun Khoon Low, May Lee |
description | Concerns on increasing trends of multidrug resistance (MDR) around the world have triggered the need to investigate and develop new therapeutic strategies and potent antibacterial drugs. Polymyxins, a class of polycationic antimicrobial peptides, have been regarded as the last-line therapy against Gram-negative bacteria due to limited new antibiotics and phenylalanine-arginine β-naphthylamide (PAβN), a peptidomimetic compound has been characterised as an efflux pump inhibitor (EPI) that have been investigated to overcome efflux-mediated multidrug resistance. In this work, the antibacterial activity of two Schiff base ligands derived from the condensation of S-benzyl dithiocarbazate with 4-carboxybenzaldehye (SB4CB) and 4-formyl-3-hydroxybenzoic acid (SBFH) their copper(II) complexes (Cu(SB4CB)
2
and Cu(SBFH)
2
) were tested individually, and the most promising compound was tested in combination with polymyxin B (POLY) and PAβN against different bacteria, such as antibiotic-susceptible strains:
Acinetobacter baumannii
ATCC 19606,
Escherichia coli
ATCC 25922,
Pseudomonas aeruginosa
ATCC 27853, and
Staphylococcus aureus
ATCC 35923; multidrug-resistant strains:
A. baumannii
ATCC BAA-1797,
E. coli
BAA-196,
P. aeruginosa
ATCC BAA-2108 and
S. aureus
ATCC 43300. Initial minimum inhibition concentration (MIC) results showed the Cu(II) complexes Cu(SB4CB)
2
and Cu(SBFH)
2
, demonstrated obvious antibacterial activity as compared to the ligand alone. Fractional inhibitory concentration (FIC) index showed improved MIC values with additivity and synergistic effect for Cu(SBFH)
2
in combination with POLY and PAβN. From the in silico molecular docking investigation, Cu(SBFH)
2
was shown to engage in hydrophobic interactions via its phenyl rings with surrounding hydrophobic residues in the binding pocket of
S. aureus
NorA,
E. coli
AcrB,
P. aeruginosa
MexB and
A. baumannii
AdeB efflux pumps. The phenyl rings of the ligand could also form π-π stacking with adjacent residues in the binding site of
A. baumannii
AdeB. Besides, hydrogen bonding and π-cation interactions were also observed via the carboxyl group, hydroxyl group and phenyl ring of SBFH moiety, respectively with nearby residues in the
E. coli
AcrB binding pocket. This study indicates that the combination strategy of Cu(SBFH)
2
with POLY and PAβN enhances therapeutic potential and sheds light on the binding pockets inside bacteria efflux pumps and the binding interactions of ligand in the binding site. |
doi_str_mv | 10.1007/s10989-021-10358-x |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2622678067</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2622678067</sourcerecordid><originalsourceid>FETCH-LOGICAL-c319t-de40c4dabdef4cf40e1ae15209126854d72a0c0d48270d0708d5748585c3c04a3</originalsourceid><addsrcrecordid>eNp9UN1OwjAYXYwmIvoCXjXxRi8qX7uObpdA_CEhSIJ625SuYyWjw3YoewLfxwfxmRxO451X5yTnLzlBcE7gmgDwnieQxAkGSjCBMIrx7iDokIiHOEyAHf5ywpLj4MT7FUBEOYFO8D4tX3WBRtvL8fgKzVVusgwNpddoVK43hd7tcWGsrExp0ZupcjQri3pd74xFw94s17YuZCGtsRoP3NLsCfr8wFO5yau80dYm1WiwlMb6Cj1LZ8qtbxZUpZ2RBZpXbi-dBkeZLLw--8Fu8HR78zi6x5OHu_FoMMEqJEmFU81AsVQuUp0xlTHQRGoSUUgI7ccRSzmVoCBlMeWQAoc4jTiLozhSoQImw25w0fZuXPmy1b4Sq3LrbDMpaJ_SPo-hzxsXbV3Kld47nYmNM2vpakFA7A8X7eGiOVx8Hy52TShsQ74x26V2f9X_pL4AM-SFzA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2622678067</pqid></control><display><type>article</type><title>Novel Cu(II) Schiff Base Complex Combination with Polymyxin B/Phenylalanine-Arginine β-Naphthylamide Against Various Bacterial Strains</title><source>SpringerLink Journals - AutoHoldings</source><creator>Gan, Wei Khang ; Liew, Hui Shan ; Pua, Lesley Jia Wei ; Ng, Xiao Ying ; Fong, Kar Wai ; Cheong, Siew Lee ; Liew, Yun Khoon ; Low, May Lee</creator><creatorcontrib>Gan, Wei Khang ; Liew, Hui Shan ; Pua, Lesley Jia Wei ; Ng, Xiao Ying ; Fong, Kar Wai ; Cheong, Siew Lee ; Liew, Yun Khoon ; Low, May Lee</creatorcontrib><description>Concerns on increasing trends of multidrug resistance (MDR) around the world have triggered the need to investigate and develop new therapeutic strategies and potent antibacterial drugs. Polymyxins, a class of polycationic antimicrobial peptides, have been regarded as the last-line therapy against Gram-negative bacteria due to limited new antibiotics and phenylalanine-arginine β-naphthylamide (PAβN), a peptidomimetic compound has been characterised as an efflux pump inhibitor (EPI) that have been investigated to overcome efflux-mediated multidrug resistance. In this work, the antibacterial activity of two Schiff base ligands derived from the condensation of S-benzyl dithiocarbazate with 4-carboxybenzaldehye (SB4CB) and 4-formyl-3-hydroxybenzoic acid (SBFH) their copper(II) complexes (Cu(SB4CB)
2
and Cu(SBFH)
2
) were tested individually, and the most promising compound was tested in combination with polymyxin B (POLY) and PAβN against different bacteria, such as antibiotic-susceptible strains:
Acinetobacter baumannii
ATCC 19606,
Escherichia coli
ATCC 25922,
Pseudomonas aeruginosa
ATCC 27853, and
Staphylococcus aureus
ATCC 35923; multidrug-resistant strains:
A. baumannii
ATCC BAA-1797,
E. coli
BAA-196,
P. aeruginosa
ATCC BAA-2108 and
S. aureus
ATCC 43300. Initial minimum inhibition concentration (MIC) results showed the Cu(II) complexes Cu(SB4CB)
2
and Cu(SBFH)
2
, demonstrated obvious antibacterial activity as compared to the ligand alone. Fractional inhibitory concentration (FIC) index showed improved MIC values with additivity and synergistic effect for Cu(SBFH)
2
in combination with POLY and PAβN. From the in silico molecular docking investigation, Cu(SBFH)
2
was shown to engage in hydrophobic interactions via its phenyl rings with surrounding hydrophobic residues in the binding pocket of
S. aureus
NorA,
E. coli
AcrB,
P. aeruginosa
MexB and
A. baumannii
AdeB efflux pumps. The phenyl rings of the ligand could also form π-π stacking with adjacent residues in the binding site of
A. baumannii
AdeB. Besides, hydrogen bonding and π-cation interactions were also observed via the carboxyl group, hydroxyl group and phenyl ring of SBFH moiety, respectively with nearby residues in the
E. coli
AcrB binding pocket. This study indicates that the combination strategy of Cu(SBFH)
2
with POLY and PAβN enhances therapeutic potential and sheds light on the binding pockets inside bacteria efflux pumps and the binding interactions of ligand in the binding site.</description><identifier>ISSN: 1573-3149</identifier><identifier>EISSN: 1573-3904</identifier><identifier>DOI: 10.1007/s10989-021-10358-x</identifier><language>eng</language><publisher>Dordrecht: Springer Netherlands</publisher><subject>Advances in peptide therapeutics ; Animal Anatomy ; Antibacterial activity ; Antibiotics ; Antimicrobial peptides ; Bacteria ; Binding sites ; Biochemistry ; Biomedical and Life Sciences ; E coli ; Escherichia coli ; Gram-negative bacteria ; Histology ; Hydrogen bonding ; Hydrophobicity ; Life Sciences ; Ligands ; Minimum inhibitory concentration ; Molecular Medicine ; Morphology ; Multidrug resistance ; Multidrug resistant organisms ; p-Hydroxybenzoic acid ; Pharmaceutical Sciences/Technology ; Pharmacology/Toxicology ; Phenylalanine ; Polymer Sciences ; Polymyxin B ; Polymyxins ; Staphylococcus aureus ; Strains (organisms)</subject><ispartof>International journal of peptide research and therapeutics, 2022-03, Vol.28 (2), Article 60</ispartof><rights>The Author(s), under exclusive licence to Springer Nature B.V. 2022</rights><rights>The Author(s), under exclusive licence to Springer Nature B.V. 2022.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c319t-de40c4dabdef4cf40e1ae15209126854d72a0c0d48270d0708d5748585c3c04a3</citedby><cites>FETCH-LOGICAL-c319t-de40c4dabdef4cf40e1ae15209126854d72a0c0d48270d0708d5748585c3c04a3</cites><orcidid>0000-0003-4321-0684</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s10989-021-10358-x$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s10989-021-10358-x$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,41488,42557,51319</link.rule.ids></links><search><creatorcontrib>Gan, Wei Khang</creatorcontrib><creatorcontrib>Liew, Hui Shan</creatorcontrib><creatorcontrib>Pua, Lesley Jia Wei</creatorcontrib><creatorcontrib>Ng, Xiao Ying</creatorcontrib><creatorcontrib>Fong, Kar Wai</creatorcontrib><creatorcontrib>Cheong, Siew Lee</creatorcontrib><creatorcontrib>Liew, Yun Khoon</creatorcontrib><creatorcontrib>Low, May Lee</creatorcontrib><title>Novel Cu(II) Schiff Base Complex Combination with Polymyxin B/Phenylalanine-Arginine β-Naphthylamide Against Various Bacterial Strains</title><title>International journal of peptide research and therapeutics</title><addtitle>Int J Pept Res Ther</addtitle><description>Concerns on increasing trends of multidrug resistance (MDR) around the world have triggered the need to investigate and develop new therapeutic strategies and potent antibacterial drugs. Polymyxins, a class of polycationic antimicrobial peptides, have been regarded as the last-line therapy against Gram-negative bacteria due to limited new antibiotics and phenylalanine-arginine β-naphthylamide (PAβN), a peptidomimetic compound has been characterised as an efflux pump inhibitor (EPI) that have been investigated to overcome efflux-mediated multidrug resistance. In this work, the antibacterial activity of two Schiff base ligands derived from the condensation of S-benzyl dithiocarbazate with 4-carboxybenzaldehye (SB4CB) and 4-formyl-3-hydroxybenzoic acid (SBFH) their copper(II) complexes (Cu(SB4CB)
2
and Cu(SBFH)
2
) were tested individually, and the most promising compound was tested in combination with polymyxin B (POLY) and PAβN against different bacteria, such as antibiotic-susceptible strains:
Acinetobacter baumannii
ATCC 19606,
Escherichia coli
ATCC 25922,
Pseudomonas aeruginosa
ATCC 27853, and
Staphylococcus aureus
ATCC 35923; multidrug-resistant strains:
A. baumannii
ATCC BAA-1797,
E. coli
BAA-196,
P. aeruginosa
ATCC BAA-2108 and
S. aureus
ATCC 43300. Initial minimum inhibition concentration (MIC) results showed the Cu(II) complexes Cu(SB4CB)
2
and Cu(SBFH)
2
, demonstrated obvious antibacterial activity as compared to the ligand alone. Fractional inhibitory concentration (FIC) index showed improved MIC values with additivity and synergistic effect for Cu(SBFH)
2
in combination with POLY and PAβN. From the in silico molecular docking investigation, Cu(SBFH)
2
was shown to engage in hydrophobic interactions via its phenyl rings with surrounding hydrophobic residues in the binding pocket of
S. aureus
NorA,
E. coli
AcrB,
P. aeruginosa
MexB and
A. baumannii
AdeB efflux pumps. The phenyl rings of the ligand could also form π-π stacking with adjacent residues in the binding site of
A. baumannii
AdeB. Besides, hydrogen bonding and π-cation interactions were also observed via the carboxyl group, hydroxyl group and phenyl ring of SBFH moiety, respectively with nearby residues in the
E. coli
AcrB binding pocket. This study indicates that the combination strategy of Cu(SBFH)
2
with POLY and PAβN enhances therapeutic potential and sheds light on the binding pockets inside bacteria efflux pumps and the binding interactions of ligand in the binding site.</description><subject>Advances in peptide therapeutics</subject><subject>Animal Anatomy</subject><subject>Antibacterial activity</subject><subject>Antibiotics</subject><subject>Antimicrobial peptides</subject><subject>Bacteria</subject><subject>Binding sites</subject><subject>Biochemistry</subject><subject>Biomedical and Life Sciences</subject><subject>E coli</subject><subject>Escherichia coli</subject><subject>Gram-negative bacteria</subject><subject>Histology</subject><subject>Hydrogen bonding</subject><subject>Hydrophobicity</subject><subject>Life Sciences</subject><subject>Ligands</subject><subject>Minimum inhibitory concentration</subject><subject>Molecular Medicine</subject><subject>Morphology</subject><subject>Multidrug resistance</subject><subject>Multidrug resistant organisms</subject><subject>p-Hydroxybenzoic acid</subject><subject>Pharmaceutical Sciences/Technology</subject><subject>Pharmacology/Toxicology</subject><subject>Phenylalanine</subject><subject>Polymer Sciences</subject><subject>Polymyxin B</subject><subject>Polymyxins</subject><subject>Staphylococcus aureus</subject><subject>Strains (organisms)</subject><issn>1573-3149</issn><issn>1573-3904</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp9UN1OwjAYXYwmIvoCXjXxRi8qX7uObpdA_CEhSIJ625SuYyWjw3YoewLfxwfxmRxO451X5yTnLzlBcE7gmgDwnieQxAkGSjCBMIrx7iDokIiHOEyAHf5ywpLj4MT7FUBEOYFO8D4tX3WBRtvL8fgKzVVusgwNpddoVK43hd7tcWGsrExp0ZupcjQri3pd74xFw94s17YuZCGtsRoP3NLsCfr8wFO5yau80dYm1WiwlMb6Cj1LZ8qtbxZUpZ2RBZpXbi-dBkeZLLw--8Fu8HR78zi6x5OHu_FoMMEqJEmFU81AsVQuUp0xlTHQRGoSUUgI7ccRSzmVoCBlMeWQAoc4jTiLozhSoQImw25w0fZuXPmy1b4Sq3LrbDMpaJ_SPo-hzxsXbV3Kld47nYmNM2vpakFA7A8X7eGiOVx8Hy52TShsQ74x26V2f9X_pL4AM-SFzA</recordid><startdate>20220301</startdate><enddate>20220301</enddate><creator>Gan, Wei Khang</creator><creator>Liew, Hui Shan</creator><creator>Pua, Lesley Jia Wei</creator><creator>Ng, Xiao Ying</creator><creator>Fong, Kar Wai</creator><creator>Cheong, Siew Lee</creator><creator>Liew, Yun Khoon</creator><creator>Low, May Lee</creator><general>Springer Netherlands</general><general>Springer Nature B.V</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88I</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M2P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><orcidid>https://orcid.org/0000-0003-4321-0684</orcidid></search><sort><creationdate>20220301</creationdate><title>Novel Cu(II) Schiff Base Complex Combination with Polymyxin B/Phenylalanine-Arginine β-Naphthylamide Against Various Bacterial Strains</title><author>Gan, Wei Khang ; Liew, Hui Shan ; Pua, Lesley Jia Wei ; Ng, Xiao Ying ; Fong, Kar Wai ; Cheong, Siew Lee ; Liew, Yun Khoon ; Low, May Lee</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c319t-de40c4dabdef4cf40e1ae15209126854d72a0c0d48270d0708d5748585c3c04a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Advances in peptide therapeutics</topic><topic>Animal Anatomy</topic><topic>Antibacterial activity</topic><topic>Antibiotics</topic><topic>Antimicrobial peptides</topic><topic>Bacteria</topic><topic>Binding sites</topic><topic>Biochemistry</topic><topic>Biomedical and Life Sciences</topic><topic>E coli</topic><topic>Escherichia coli</topic><topic>Gram-negative bacteria</topic><topic>Histology</topic><topic>Hydrogen bonding</topic><topic>Hydrophobicity</topic><topic>Life Sciences</topic><topic>Ligands</topic><topic>Minimum inhibitory concentration</topic><topic>Molecular Medicine</topic><topic>Morphology</topic><topic>Multidrug resistance</topic><topic>Multidrug resistant organisms</topic><topic>p-Hydroxybenzoic acid</topic><topic>Pharmaceutical Sciences/Technology</topic><topic>Pharmacology/Toxicology</topic><topic>Phenylalanine</topic><topic>Polymer Sciences</topic><topic>Polymyxin B</topic><topic>Polymyxins</topic><topic>Staphylococcus aureus</topic><topic>Strains (organisms)</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gan, Wei Khang</creatorcontrib><creatorcontrib>Liew, Hui Shan</creatorcontrib><creatorcontrib>Pua, Lesley Jia Wei</creatorcontrib><creatorcontrib>Ng, Xiao Ying</creatorcontrib><creatorcontrib>Fong, Kar Wai</creatorcontrib><creatorcontrib>Cheong, Siew Lee</creatorcontrib><creatorcontrib>Liew, Yun Khoon</creatorcontrib><creatorcontrib>Low, May Lee</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><jtitle>International journal of peptide research and therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gan, Wei Khang</au><au>Liew, Hui Shan</au><au>Pua, Lesley Jia Wei</au><au>Ng, Xiao Ying</au><au>Fong, Kar Wai</au><au>Cheong, Siew Lee</au><au>Liew, Yun Khoon</au><au>Low, May Lee</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Novel Cu(II) Schiff Base Complex Combination with Polymyxin B/Phenylalanine-Arginine β-Naphthylamide Against Various Bacterial Strains</atitle><jtitle>International journal of peptide research and therapeutics</jtitle><stitle>Int J Pept Res Ther</stitle><date>2022-03-01</date><risdate>2022</risdate><volume>28</volume><issue>2</issue><artnum>60</artnum><issn>1573-3149</issn><eissn>1573-3904</eissn><abstract>Concerns on increasing trends of multidrug resistance (MDR) around the world have triggered the need to investigate and develop new therapeutic strategies and potent antibacterial drugs. Polymyxins, a class of polycationic antimicrobial peptides, have been regarded as the last-line therapy against Gram-negative bacteria due to limited new antibiotics and phenylalanine-arginine β-naphthylamide (PAβN), a peptidomimetic compound has been characterised as an efflux pump inhibitor (EPI) that have been investigated to overcome efflux-mediated multidrug resistance. In this work, the antibacterial activity of two Schiff base ligands derived from the condensation of S-benzyl dithiocarbazate with 4-carboxybenzaldehye (SB4CB) and 4-formyl-3-hydroxybenzoic acid (SBFH) their copper(II) complexes (Cu(SB4CB)
2
and Cu(SBFH)
2
) were tested individually, and the most promising compound was tested in combination with polymyxin B (POLY) and PAβN against different bacteria, such as antibiotic-susceptible strains:
Acinetobacter baumannii
ATCC 19606,
Escherichia coli
ATCC 25922,
Pseudomonas aeruginosa
ATCC 27853, and
Staphylococcus aureus
ATCC 35923; multidrug-resistant strains:
A. baumannii
ATCC BAA-1797,
E. coli
BAA-196,
P. aeruginosa
ATCC BAA-2108 and
S. aureus
ATCC 43300. Initial minimum inhibition concentration (MIC) results showed the Cu(II) complexes Cu(SB4CB)
2
and Cu(SBFH)
2
, demonstrated obvious antibacterial activity as compared to the ligand alone. Fractional inhibitory concentration (FIC) index showed improved MIC values with additivity and synergistic effect for Cu(SBFH)
2
in combination with POLY and PAβN. From the in silico molecular docking investigation, Cu(SBFH)
2
was shown to engage in hydrophobic interactions via its phenyl rings with surrounding hydrophobic residues in the binding pocket of
S. aureus
NorA,
E. coli
AcrB,
P. aeruginosa
MexB and
A. baumannii
AdeB efflux pumps. The phenyl rings of the ligand could also form π-π stacking with adjacent residues in the binding site of
A. baumannii
AdeB. Besides, hydrogen bonding and π-cation interactions were also observed via the carboxyl group, hydroxyl group and phenyl ring of SBFH moiety, respectively with nearby residues in the
E. coli
AcrB binding pocket. This study indicates that the combination strategy of Cu(SBFH)
2
with POLY and PAβN enhances therapeutic potential and sheds light on the binding pockets inside bacteria efflux pumps and the binding interactions of ligand in the binding site.</abstract><cop>Dordrecht</cop><pub>Springer Netherlands</pub><doi>10.1007/s10989-021-10358-x</doi><orcidid>https://orcid.org/0000-0003-4321-0684</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1573-3149 |
ispartof | International journal of peptide research and therapeutics, 2022-03, Vol.28 (2), Article 60 |
issn | 1573-3149 1573-3904 |
language | eng |
recordid | cdi_proquest_journals_2622678067 |
source | SpringerLink Journals - AutoHoldings |
subjects | Advances in peptide therapeutics Animal Anatomy Antibacterial activity Antibiotics Antimicrobial peptides Bacteria Binding sites Biochemistry Biomedical and Life Sciences E coli Escherichia coli Gram-negative bacteria Histology Hydrogen bonding Hydrophobicity Life Sciences Ligands Minimum inhibitory concentration Molecular Medicine Morphology Multidrug resistance Multidrug resistant organisms p-Hydroxybenzoic acid Pharmaceutical Sciences/Technology Pharmacology/Toxicology Phenylalanine Polymer Sciences Polymyxin B Polymyxins Staphylococcus aureus Strains (organisms) |
title | Novel Cu(II) Schiff Base Complex Combination with Polymyxin B/Phenylalanine-Arginine β-Naphthylamide Against Various Bacterial Strains |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T05%3A55%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Novel%20Cu(II)%20Schiff%20Base%20Complex%20Combination%20with%20Polymyxin%20B/Phenylalanine-Arginine%20%CE%B2-Naphthylamide%20Against%20Various%20Bacterial%20Strains&rft.jtitle=International%20journal%20of%20peptide%20research%20and%20therapeutics&rft.au=Gan,%20Wei%20Khang&rft.date=2022-03-01&rft.volume=28&rft.issue=2&rft.artnum=60&rft.issn=1573-3149&rft.eissn=1573-3904&rft_id=info:doi/10.1007/s10989-021-10358-x&rft_dat=%3Cproquest_cross%3E2622678067%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2622678067&rft_id=info:pmid/&rfr_iscdi=true |